Agrx discussion
WebApr 6, 2024 · Maxim Group downgrades Agile Therapeutics (AGRX) to a Hold March 25, 2024TipRanks. Agile Therapeutics Reports Fourth Quarter & Full Year 2024 Financial … WebMar 22, 2024 · AGRX US00847L3087. AGILE THERAPEUTICS, INC. (A3D7A3) Zur Watchlist hinzufügen. Bericht. Verzögert ... AGILE THERAPEUTICS INC Management's Discussion and Analysis of Financial Condition and.. AQ. 23.03. Agile Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt: CI. 22.03.
Agrx discussion
Did you know?
WebApr 10, 2024 · Company Profile AGRX Business Description Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product … WebAgile Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AGRX updated stock price target summary.
WebI sold out of agrx a year ago at $3 and just eat the loss. Looking at it now I'm glad I dodged that bullet. Ever since the FDA approval it's just been constant battles with covid, delays, offerings. I haven't kept up enough to know the full nitty gritty details. Stock with constant bad luck. 2 Reply Share Report Save Follow WebAGRX Stock Discussion. Agile Therapeutics, Inc. Description. Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development.
WebALGRX 3268, our most advanced product candidate, is a powder formulation of the local anesthetic lidocaine delivered into the skin using our proprietary needle-free dispenser. … WebAug 15, 2024 · On August 15, 2024, Agile Therapeutics, Inc. (the "Company") received a deficiency letter from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company's common stock was below the minimum …
WebAgile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2024 Earnings Call Transcript Market Screener 1 week ago AGILE THERAPEUTICS REPORTS FOURTH QUARTER AND …
WebThe Wall Street analyst predicted. that Agile Therapeutics's share price could reach $150.00 by Dec 30, 2024. What is AGRX's forecast return on assets (ROA) for 2024-2026? (NASDAQ: AGRX) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.05%. tpsn alabang town centerWebFind real-time AGRX - Agile Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. AGRX - Agile Therapeutics Inc Stock quote - … tps naiset facebookWebJun 28, 2024 · Agile Therapeutics Inc (NASDAQ: AGRX) shareholders have witnessed a decrease in activity from the world's largest hedge funds in recent months. Agile Therapeutics Inc (NASDAQ: AGRX) was in 6... tpsn alabang town center contact numberWeb52 rows · Jun 23, 2014 · Agile Therapeutics, Inc. (AGRX) Message Board - Company … tpsn armyWebApr 13, 2024 · Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for AGRX stock is $ 5.1 , which predicts a decrease of -37.58%. The lowest target is $ 5.05 and the highest is $ 5.25. On average, analysts rate AGRX stock as … tpsnc02/reportsWebAGRX Stock Discussion. Agile Therapeutics, Inc. Description. Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization … thermostat glassWeb12 hours ago · View Agile Therapeutics, Inc AGRX investment & stock information. Get the latest Agile Therapeutics, Inc AGRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. thermostat girish ego